News
Though behavioral health conditions do not discriminate between Democrats and Republicans, the Medicaid cuts may be ...
This happens because the nervous system becomes more sensitive over time, causing you to feel more pain even after the ...
U.S. Senator Steve Daines and Rep. Ryan Zinke have joined other legislators in introducing the bipartisan “Protection for Reservation Occupants Against Trafficking and Evasive Communications Today ...
US FDA approves Azurity Pharma’s Xifyrm for management of moderate-to-severe pain in adults: Woburn, Massachusetts Thursday, June 12, 2025, 12:00 Hrs [IST] Azurity Pharmaceutica ...
Attorney General Russell Coleman announced Monday a funding opportunity to support research that addresses the drug epidemic in Kentucky.
New, non-opioid molecule acts like a long-lasting anesthetic, relieving chronic pain for three weeks
A new molecule acts like a local, long-lasting anesthetic, providing robust pain relief for up to three weeks.
The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...
The Opioid Abatement Advisory Commission (KYOAAC) voted to allocate funding for a special grant opportunity for projects ...
New York should empower paramedics to administer Suboxone, a proven addiction treatment tool, as part of a modern, evolving strategy to combat the opioid epidemic.
The statistics are cause for optimism. But now is not the time to scale back the work.
Kentucky Attorney General has announced a $5 million grant opportunity through the Kentucky Opioid Abatement Advisory ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results